Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 60

Sort by

Sort Order Select

Journal Articles

Genomic Landscape of Sex Disparities in Multiple Myeloma

Susan Bal, MDMBBS, Kwangmin Choi, PhD, Omer Jamy, MD, Saulius K. Girnius, MD, Heather J Landau, MD, Luciano J. Costa, MD PhD

Blood (2019) 134 (Supplement_1): 3067.

https://doi.org/10.1182/blood-2019-127429

Published: 2019

Journal Articles

The Validation of the BCR/ABL1 -like Predictor across Laboratories Shows Reproducibility of Results

Sabina Chiaretti, MD PhD, Taherinasab Akram, Canichella Martina, Monica Messina, Alfonso Piciocchi, Cyril Šálek, MD PhD, Katerina Machova, Katerina Blagoevova, Jordi Ribera, PhD, Josep-Maria Ribera, MD PhD, Manja Meggendorfer, PhD, Claudia Haferlach, MD, Anna Guarini, PhD, Robin Foà, MD

Blood (2019) 134 (Supplement_1): 5211.

https://doi.org/10.1182/blood-2019-122116

Published: 2019

Journal Articles

Primary Antigen Aberrations and Immunophenotype Shifts of Blasts in AML Patients during the Treatment and at the Time of Relapse

Tatiana I. Lobanova, MD, Elena N. Parovichnikova, MD PhD, Irina V. Galtseva, MD PhD, Vera V. Troitskaya, MD PhD, Julia O. Davydova, Nikolay M. Kapranov, Andrey N. Sokolov, MD PhD, Sergei M. Kulikov, PhD, Valery G. Savchenko, MD PhD academician

Blood (2019) 134 (Supplement_1): 5183.

https://doi.org/10.1182/blood-2019-128650

Published: 2019

Journal Articles

Mutational Profile of Leukemic Stem Cells in FLT3 -ITD Mutated AML

Blood (2019) 134 (Supplement_1): 1458.

https://doi.org/10.1182/blood-2019-126040

Published: 2019

Journal Articles

Functional Analysis of CD99 Upregulation in Acute Myeloid Leukemia

Vijaya Pooja Vaikari, MS, Jiawen Yang, BS, Mojtaba Akhtari, MD, Houda Alachkar, PharmD, PhD

Blood (2018) 132 (Supplement 1): 5129.

https://doi.org/10.1182/blood-2018-99-120348

Published: 2018

Journal Articles

Single-Cell Mass Cytometry Characterizes Phenotypic and Functional Heterogeneity in Acute Myeloid Leukemia at Diagnosis, in Remission and Relapse

Lina Han, PhD, Peng Qiu, PhD, Jeffrey L. Jorgensen, MD PhD, Duncan Mak, BSc, MPhil, Jared K Burks, PhD, Teresa McQueen, MS, Zhihong Zeng, MD, Farhad Ravandi, MD, Gail J. Roboz, MD, Hagop M. Kantarjian, MD, Steven M. Kornblau, MD, Michael Andreeff, MD PhD, Monica L. Guzman, PhD, Marina Y. Konopleva, MD PhD

Blood (2018) 132 (Supplement 1): 912.

https://doi.org/10.1182/blood-2018-99-111970

Published: 2018

Journal Articles

Different Treatment Regimens, Optimal Time Points and Threshold Level While Minimal Residual Disease Evaluation in AML Patients

Tatiana I. Lobanova, MD, Irina V. Galtseva, PhD, Yuliya O. Davydova, Nikolay M. Kapranov, Vera V. Troitskaya, MD PhD, Irina A. Lukyanova, MD, Elena Parovichnikova, MD PhD, Sergei M. Kulikov, PhD, Larisa Kuzmina, PhD, Valery G. Savchenko, MD PhD academician

Blood (2018) 132 (Supplement 1): 2808.

https://doi.org/10.1182/blood-2018-99-114669

Published: 2018

Journal Articles

Interaction between FLT3 and CD99 in Acute Myeloid Leukemia

Vijaya Pooja Vaikari, MS, Sharon Wu, BS, Tian Zhang, BS, Sasha Kartman, Manal Abdi, Klaus H. Metzeler, MD, Mojtaba Akhtari, MD, Houda Alachkar, PharmD, PhD

Blood (2017) 130 (Supplement 1): 3786.

https://doi.org/10.1182/blood.V130.Suppl_1.3786.3786

Published: 2017

Journal Articles

CD99 Regulates Normal and Malignant Stem Cell Function By Restricting Protein Translation

Stephen S. Chung, MD, Wenhuo Hu, PhD, Liang Guo, PhD, Lavanya Kannan, PhD, Ross L. Levine, MD, Christopher Y. Park, MD PhD

Blood (2017) 130 (Supplement 1): 3749.

https://doi.org/10.1182/blood.V130.Suppl_1.3749.3749

Published: 2017

Journal Articles

Aggresive Lymphoma—Leukemia Presenting As a Solitary Bone Tumor and Mimicking Ewing's Sarcoma

Rejin Kebudi, MD, Omer Gorgun, MD, Oner Dogan, MD

Blood (2017) 130 (Supplement 1): 5226.

https://doi.org/10.1182/blood.V130.Suppl_1.5226.5226

Published: 2017

Journal Articles

Endothelial CD99 supports arrest of mouse neutrophils in venules and binds to neutrophil PILRs

Debashree Goswami, Sigrid März, Yu-Tung Li, Annette Artz, Kerstin Schäfer, Ruth Seelige, Mariana Pacheco-Blanco, Ding Jing, Maria Gabriele Bixel, Masatake Araki, Kimi Araki, Ken-Ichi Yamamura, Dietmar Vestweber

Blood (2017) 129 (13): 1811–1822.

https://doi.org/10.1182/blood-2016-08-733394

Published: 2017

Includes: Multimedia, Supplemental data

Journal Articles

Stem and progenitor cell alterations in myelodysplastic syndromes

Aditi Shastri, Britta Will, Ulrich Steidl, Amit Verma

Blood (2017) 129 (12): 1586–1594.

https://doi.org/10.1182/blood-2016-10-696062

Published: 2017

Journal Articles

CD99 Is Highly Expressed in Acute Myeloid Leukemia (AML) and Presents a Viable Therapeutic Target

Vijaya Pooja Vaikari, MS, Miran Jang, PhD, Mojtaba Akhtari, MD, Houda Alachkar, PhD PharmD

Blood (2016) 128 (22): 1540.

https://doi.org/10.1182/blood.V128.22.1540.1540

Published: 2016

Journal Articles

Aberrant Precursor B Lymphoid Blast Population in a Patient with Juvenile Myelomonocytic Leukemia

Saman Khalid Hashmi, MD, Jyotinder Nain Punia, MD, Amos S. Gaikwad, PhD, Kevin E. Fisher, MD PhD, Angshumoy Roy, MD PhD, Dolores H. Lopez-Terrada, MD PhD, Pulivarthi Rao, PhD, Jo Ringrose, CG(ASCP), Andrea N. Marcogliese, MD, Rachel E Rau, MD

Blood (2016) 128 (22): 5557.

https://doi.org/10.1182/blood.V128.22.5557.5557

Published: 2016

Journal Articles

Proteomic Analysis Directs Effective Drug Selection in Relapsed AML By Quantifying Drug Targets

David J Britton, PhD, Edmund Wilkes, BSc, PhD, Pedro Casado, PhD, Vinothini Rajeeve, PhD, Jude Fitzgibbon, John Gribben, Pedro R Cutillas, BSc, PhD

Blood (2016) 128 (22): 5265.

https://doi.org/10.1182/blood.V128.22.5265.5265

Published: 2016

Journal Articles

Targeting CD99 in T-Cell Neoplasms with Monoclonal Antibodies

Montreh Tavakkoli, MA, Dong H. Lee, MD, Benjamin Durham, MD PhD, Stephen S. Chung, MD, Christopher Y. Park, MD, PhD

Blood (2015) 126 (23): 2749.

https://doi.org/10.1182/blood.V126.23.2749.2749

Published: 2015

Journal Articles

CD99 Is a Therapeutic Target on Disease Initiating Stem Cells in Acute Myeloid Leukemia and the Myelodysplastic Syndromes

Stephen S. Chung, MD, Montreh Tavakkoli, BS, Virginia M. Klimek, MD, Christopher Y. Park, MD PhD

Blood (2014) 124 (21): 3760.

https://doi.org/10.1182/blood.V124.21.3760.3760

Published: 2014

Journal Articles

Profiling Myelodysplastic Syndromes By Mass Cytometry Demonstrates Distinct Immunophenotypic Aberrancies in Stem and Progenitor Populations

Gregory K. Behbehani, MD PhD, Rachel Finck, B.S., Nikolay Samusik, PhD, Pier Federico Gherardini, PhD, Kunju J Sridhar, PhD, Wendy J. Fantl, PhD, Peter L. Greenberg, MD, Garry P. Nolan, PhD

Blood (2014) 124 (21): 1903.

https://doi.org/10.1182/blood.V124.21.1903.1903

Published: 2014

Journal Articles

Unsupervised Discovery of Early Markers of Erythroid Maturation in Human Donor Marrow

David P Ng, MD, Brent Wood, MD PhD

Blood (2014) 124 (21): 4304.

https://doi.org/10.1182/blood.V124.21.4304.4304

Published: 2014

Journal Articles

Presence of MLL Gene Rearrangements in Infant Acute Leukemia Could be Predicted By Tumor cells’ Immunophenotype

Alexander Popov, MD PhD, Grigory Tsaur, MD PhD, Tatiana Verzhbitskaya, MD PhD, Olga Streneva, MD PhD, Egor Shorikov, MD PhD, Leonid Saveliev, MD PhD, Larisa Fechina, MD PhD

Blood (2014) 124 (21): 5359.

https://doi.org/10.1182/blood.V124.21.5359.5359

Published: 2014

NARROW

Genomic Landscape of Sex Disparities in Multiple Myeloma

The Validation of the BCR/ABL1 -like Predictor across Laboratories Shows Reproducibility of Results

Primary Antigen Aberrations and Immunophenotype Shifts of Blasts in AML Patients during the Treatment and at the Time of Relapse

Mutational Profile of Leukemic Stem Cells in FLT3 -ITD Mutated AML

Functional Analysis of CD99 Upregulation in Acute Myeloid Leukemia

Single-Cell Mass Cytometry Characterizes Phenotypic and Functional Heterogeneity in Acute Myeloid Leukemia at Diagnosis, in Remission and Relapse

Different Treatment Regimens, Optimal Time Points and Threshold Level While Minimal Residual Disease Evaluation in AML Patients

Interaction between FLT3 and CD99 in Acute Myeloid Leukemia

CD99 Regulates Normal and Malignant Stem Cell Function By Restricting Protein Translation

Aggresive Lymphoma—Leukemia Presenting As a Solitary Bone Tumor and Mimicking Ewing's Sarcoma

Endothelial CD99 supports arrest of mouse neutrophils in venules and binds to neutrophil PILRs

Stem and progenitor cell alterations in myelodysplastic syndromes

CD99 Is Highly Expressed in Acute Myeloid Leukemia (AML) and Presents a Viable Therapeutic Target

Aberrant Precursor B Lymphoid Blast Population in a Patient with Juvenile Myelomonocytic Leukemia

Proteomic Analysis Directs Effective Drug Selection in Relapsed AML By Quantifying Drug Targets

Targeting CD99 in T-Cell Neoplasms with Monoclonal Antibodies

CD99 Is a Therapeutic Target on Disease Initiating Stem Cells in Acute Myeloid Leukemia and the Myelodysplastic Syndromes

Profiling Myelodysplastic Syndromes By Mass Cytometry Demonstrates Distinct Immunophenotypic Aberrancies in Stem and Progenitor Populations

Unsupervised Discovery of Early Markers of Erythroid Maturation in Human Donor Marrow

Presence of MLL Gene Rearrangements in Infant Acute Leukemia Could be Predicted By Tumor cells’ Immunophenotype

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only